FDA warned pregnant and breast-feeding women yesterday to avoid CBD, THC and marijuana in any form, including the proliferation of food, supplements and cosmetics containing CBD and other cannabis-derived ingredients that currently are flooding the market...
The International Probiotics Association will host its fourth IPA DC Workshop with insights from a range of experts and stakeholders, including the FDA/ CFSAN, FTC, and Health Canada. The event is held in conjunction with the US Pharmacopeia.
Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
AdvoCare, a multi-level marketing company, has agreed to a $150 million fine and a compensation plan restructuring to settle an FTC pyramid scheme case. In addition, the former CEO has agreed to a ban from the industry.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.